Company
Context Therapeutics Inc.
Context Therapeutics Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| CTIM-76 | Phase 1 | Platinum-resistant Ovarian Cancer |
Latest
Follow Context Therapeutics Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.